NCT00328458View on ClinicalTrials.gov

EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2009

Conditions

Central Nervous System NeoplasmsHead and Neck Neoplasms

Interventions

DRUG

EPO906 (epothilone B)

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER